Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009 (Q36133754)

12 August 2017

Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009 (English)

1 reference

12 August 2017

1 reference

4

Abbey B Berenson

1 reference

12 August 2017

Jacqueline M Hirth

1

1 reference

12 August 2017

Alai Tan

series ordinal

2

1 reference

12 August 2017

Gregg S Wilkinson

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

27 April 2012

1 reference

12 August 2017

1 reference

12 August 2017

118

1 reference

12 August 2017

22

1 reference

12 August 2017

5623-5629

1 reference

Cervical adenocarcinoma: moving towards better prevention

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Prevalence of HPV infection among females in the United States

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Patient reminder and recall systems to improve immunization rates

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

The HPV vaccine: are dosing recommendations being followed?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

HPV vaccine against anal HPV infection and anal intraepithelial neoplasia

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Impact of vaccinating boys and men against HPV in the United States

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

Factors associated with completion of the human papillomavirus vaccine series

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3410047

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.27598

Incremental Impact of Adding Boys to Current Human Papillomavirus Vaccination Programs: Role of Herd Immunity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.27598

Vaccination coverage and physician distribution in the United States, 1997

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22544681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Text message reminders to promote human papillomavirus vaccination

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22544681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CNCR.27598

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22544681

1 reference